血清和组织利波卡林-2表达在慢性脏疾病患者
Heba A S Bazid1, Hanaa G Sakr1, Rania A Abdallah2
1Department of Dermatology, Andrology and STDS, Faculty of Medicine, Menoufia University.
Applied immunohistochemistry & molecular morphology : AIMM
|September 12, 2023
概括
在患有尿性的慢性病 (CKD) 患者中,利波卡林-2 (LCN2) 的水平升高. 狭带UVB治疗后LCN2水平降低与减少相关,这表明LCN2
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 尿液性是末期病患者常见和令人痛苦的症状.
- 利波卡林-2 (LCN2) 在免疫和损伤进展中起作用.
研究的目的:
- 调查慢性病 (CKD) 患者的血清和皮肤中的Lipocalin-2 (LCN2) 表达.
- 为了将LCN2水平与临床参数相关联,并评估窄带紫外线B (UVB) 光疗的影响.
主要方法:
- 使用酶相关免疫吸收试验 (ELISA) 测量血清LCN2水平.
- 免疫组织化学被用来评估皮肤LCN2表达.
- 研究了25名CKD患者和25名健康对照组;10名CKD患者接受了12周的窄带UVB治疗.
主要成果:
- 与对照组相比,CKD患者在皮肤和血清中表现出明显更高的LCN2表达.
- 血清LCN2水平升高与的严重程度,CKD等级,尿素和肌素相关.
- 窄带UVB疗法降低了LCN2水平,改善了症状.
结论:
- 血清和组织中LCN2表达的增加与尿素性的发病有关.
- LCN2可以作为尿性的潜在生物标志物和治疗干预的目标.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
29
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
29
Nephrotic Syndrome I : Introduction
9
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Nephrotic Syndrome III : Nursing Management
19
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
19
Chronic Kidney Disease III: Interprofessional Care
41
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
41
Chronic Kidney Disease I: Introduction
33
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
33


